FDA’s Social Media Guidance Gives Firms A Pass On User-Generated Content
Executive Summary
The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.
You may also be interested in...
Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication
Pfizer social media announcement that it’s seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA’s ability to regulate pharma on social media, and the unique considerations of promotion under EUAs.
Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication
Pfizer social media announcement that it’s seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA’s ability to regulate pharma on social media, and the unique considerations of promotion under EUAs.
Will #Cures2015 Fix Twitter Promotion?
House 21st Century Cures discussion draft would adjust FDA promotion regulations for Twitter, requiring that information communicated through hyperlink be considered part of the original post.